Bial R&D Investments S.A.

Research activity is centred on Parkinson’s disease, with a particular focus on motor symptom progression and clinical outcomes measured through established neurological rating scales.

• Motor progression
• Movement disorder assessment
• Clinical symptom evaluation

The sponsor’s trials are aligned with the study of functional impairment in Parkinson’s disease and the monitoring of changes in daily living and motor performance.